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RAMALAN STRUKTUR DAN REKA BENTUK SCFV UNTUK BMR1 
ANTIGEN DARIPADA BRUGIA MALAYI 
ABSTRAK 
Filariasis limfatik yang disebabkan oleh salah satu cacing filaria, Brugia 
malayi, telah dikenalpasti oleh Badan Kesihatan Sedunia untuk dihapuskan sejak 
tahun 1997. Antigen rekombinan daripada B. malayi (BmR1) telah menunjukkan 
spesifisiti dan sensitiviti yang tinggi dalam ujian pengesanan antibodi terhadap 
filariasis brugian (Brugia Rapid). Maka, antigen ini merupakan calon yang unggul 
untuk pembangunan ujian pengesanan antigen untuk melengkapkan Brugia Rapid. 
Dalam kajian ini, pendekatan siliko telah dilaksanakan untuk mendapat struktur tiga 
dimensi bagi antigen BmR1, mengkaji domain fungsi, meramalkan epitop yang 
berpontesi dan reka bentuk rantai tunggal fragmen Fv (scFv) spesifik terhadap BmR1. 
Di sini, ramalan struktur telah diperolehi melalui pendekatan pemodelan 
perbandingan, „threading‟ dan ab initio. Penilaian menunjukkan bahawa struktur yang 
diramalkan dengan pendekatan ab initio (Rosetta) paling optimum di kalangan semua 
struktur. Struktur yang telah diperhaluskan dan dioptimalkan lagi telah menunjukkan 
kestabilan dan kualiti yang baik sepanjang 5 ns dinamik simulasi molekul. Tiga epitop 
berpotensi (residu 37-47, 104-112 dan 125-148) telah diramalkan oleh server epitop 
linear dan konformasi. ScFv spesifik terhadap epitop-epitop ini telah direka melalui 
dua langkah utama: generasi „hot spot libraries‟ dan konfigurasi bentuk saling 
melengkapi. Sebanyak 200 reka bentuk dengan tenaga ikatan (<-20 R.E.U) and 
bentuk saling melengkapi (Sc>0.5) telah diperolehi. Residu-residu penting dalam 
peningkatan interaksi dengan antigen BmR1 telah dikenalpasti. Reka bentuk scFv ini 
diramalkan sangat spesifik terhadap antigen BmR1 dan mungkin dapat digunakan 
dalam ujian in vitro sebelum pembangunan ujian pengesanan berdasarkan antigen.  
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STRUCTURE PREDICTION AND SCFV DESIGN AGAINST BMR1 
ANTIGEN OF BRUGIA MALAYI 
ABSTRACT 
 Lymphatic filariasis which is caused by one of the filarial nematode, Brugia 
malayi, has been identified by World Health Organization for elimination since year 
1997. The recombinant antigen from B. malayi (BmR1) was found to be highly 
specific and sensitive in the antibody detection test against brugian filariasis (Brugia 
Rapid). Therefore, this antigen is an ideal candidate for the development of antigen 
detection test to complement the current Brugia Rapid. In this study, computational 
approach was implemented to obtain three-dimensional structure of BmR1 antigen, to 
study the functional domain, to predict the potential epitopes and to design single 
chain variable fragment (scFv) specific to BmR1. Predictive structures were obtained 
via comparative modelling, threading and ab initio approaches. Evaluation studies 
showed that the structure built by ab initio (Rosetta) was the most optimal compared 
to structures built by other methods. The further refined and optimized structure was 
shown to be stable and posses good quality throughout 5 ns of molecular dynamics 
simulations. Three potential epitopes (residues 37-49, 104-112 and 125-148) were 
predicted by linear and conformational epitopes prediction server. Specific scFv 
towards these epitopes were designed using two main methods: the generation of hot 
spot libraries and high shape complementarity conformations. A total of 200 scFv 
designs with binding energy (<-20 R.E.U) and shape complementarity (Sc>0.5) were 
obtained. Key residues that played crucial roles in enhancing the interactions with 
BmR1 antigen were also identified. These designed scFv were predicted to be highly 
specific towards the BmR1 antigen and may be useful for in vitro testing prior to the 
development of antigen detection test. 
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CHAPTER ONE 
GENERAL OVERVIEW 
 
1.1 Introduction 
Lymphatic filariasis has been identified as one of the leading causes of 
permanent and long-term disability and has been targeted for elimination by the year 
2020 (World Health Organization, 2011). Therefore, the availability of an easy on-site 
lymphatic filariasis diagnostic test which is rapid, affordable and accessible for 
disease management and therapy is one of the important factors for the ongoing 
lymphatic filariasis elimination programme (Noordin et al., 2004; Noordin, 2007; 
Rahman et al., 2007). Earlier studies showed that Brugia malayi recombinant antigen 
(BmR1) expressed from Bm17DIII gene has been employed in ELISA and rapid 
immunochromatographic dipstick test format (Brugia Rapid) for specific and sensitive 
detection of anti-filarial IgG4 antibodies against brugian filariasis (Rahmah et al., 
2001a; Noordin et al., 2007; Rahman et al., 2007). Studies also showed that the BmR1 
recombinant antigen is a highly specific and sensitive marker, thus making it a 
promising candidate for the detection of IgG4 antibody for brugian filariasis (Noordin 
et al., 2004; Rahman et al., 2007; Noordin et al., 2007). The development of a 
specific and sensitive BmR1 antigen detection test would also be a complement to 
currently available antibody detection test (Brugia Rapid) for detection of active 
lymphatic filariasis infection (Rahmah et al., 2001b; Noordin et al., 2004; Rahman et 
al., 2007). Thus, this study is to model and identify epitopes of BmR1 antigen and 
subsequently to design binders, namely single chain variable fragment (scFv), specific 
against BmR1 antigen.  
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1.2 Lymphatic filariasis  
Lymphatic filariasis (LF) is a neglected disease caused by filarial nematodes 
namely Wuchereria bancrofti, Brugia malayi and Brugia timori. W. bancrofti 
(bancroftian filariasis) accounts for 90% of LF infection while the remaining 10% is 
by B. malayi and B. timori (brugian filariasis; commonly found in Asia countries). LF, 
also known as elephantiasis, has infected over 120 million people worldwide and it is 
estimated that nearly 1.4 billion people are at risk of infection (World Health 
Organization, 2011). Due to this, WHO has launched the Global Programme for the 
Elimination of Lymphatic Filariasis (GPELF) in the year 2000 with two principal 
goals: to interrupt the transmission and to alleviate the disability (reduce morbidity) 
caused by LF (Ottesen, 2000). In conjunction with the program, National Lymphatic 
Filariasis Elimination Programme was being introduced in 2001 by Ministry of Health 
Malaysia and WHO (Ministry of Health Malaysia, 2004; Hamid, 2012). Although 
statistic showed that the number of LF cases had decreased over the years (from 528 
cases in 1999 to 267 cases in 2012) (Ministry of Health Malaysia, 2012), LF still 
remains as a public health problem in the states of Johor, Kedah, Kelantan, Pahang, 
Perak, Terengganu, Sabah and Sarawak (Noordin, 2007; Talip, 2014).   
LF is transmitted to human by mosquitoes such as Culex, Anopheles, Aedes 
and Mansonia (Erickson et al., 2009). When an infected mosquito (intermediate host) 
takes a blood, it deposits infective third stage larvae (L3) into human (definitive host). 
The larvae are then mature and develop into lymph-dwelling adult worms that reside 
in the lymphatic vessels. Adult female worms produce hundreds to thousands of 
sheathed microfilariae (Mf) daily and are then ingested by mosquitoes during a blood 
meal, thereby completing the life cycle of B. malayi (Figure 1.1) (Centers for Disease 
Control and Prevention, 2010).   
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Figure 1.1 Life cycle of Brugia malayi in the mosquito (intermediate host) and 
human (definitive host) adopted from Centers for Disease Control and Prevention, 
2010.  
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1.3 Symptoms and treatment of lymphatic filariasis 
LF patients show different clinical symptoms ranging from no evident of 
clinical disease to overt clinical manifestation. Clinical manifestations of lymphatic 
filariasis can be further divided into asymptomatic stage, acute manifestation 
(inflammatory episodes) and chronic manifestation (lymphoedema, elephantiasis and 
hydrocele). The most common clinical manifestation is the asymptomatic stage. 
Individuals in this asymptomatic stage are carriers of the infection and the reservoir 
for the ongoing transmission of the disease (Babu and Nutman, 2012; Centers for 
Disease Control and Prevention, 2013). Acute manifestation is characterized by 
recurrent attacks of fever associated with the local inflammation of the skin, lymph 
nodes (lymphadenitis) and lymphatic vessels (lymphangitis) (Babu et al., 2005; Babu 
and Nutman, 2012). Lymphoedema (tissue swelling) and elephantiasis (skin/tissue 
thickening) are more commonly observed in brugian filariasis during chronic 
manifestation. They are developed at the leg, arm, scrotum, vulva and breast of the 
infected individuals (Partono, 2007). Lymphoedema or swelling of the limbs is a 
common progression from acute manifestation and is due to the malfunction of 
lymphatic vessels by the adult worms. When lymphoedema (Figure 1.2 a) becomes 
severe, it is often referred to as elephantiasis (Figure 1.2 b). 
LF treatment under GPELF mainly focuses on mass drug administration with 
single-dose diethylcarbamazine or ivermectin combined with albendazole. These 
drugs are to interrupt transmission of LF and morbidity alleviation. The drugs can 
eliminate the Mf from bloodstream and annual drug regimens need to be administered 
for at least 5 years continuously (World Health Organization, 2011). For effective 
control of LF, it lies in early diagnosis, appropriate treatment and follow-up of drug 
administration.  
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Figure 1.2 Chronic manifestation of lymphatic filariasis. (a) Lymphoedema and (b) 
Elephantiasis (Babu and Nutman, 2009; Centers for Disease Control and Prevention, 
2013). 
  
(a) 
(b) 
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1.4 Lymphatic filariasis diagnosis   
LF mainly affects those who reside in remote areas and with limited health 
and laboratory facilities. Besides, most of the LF patients have silent manifestations 
that have no symptoms (asymptomatic) and did not develop clinical symptom. The 
infections remain unknown in some cases unless tested or showed clinical signs. Thus, 
on-site diagnosis which is simple, rapid and accessible are essentials for the LF 
elimination in order for early detection and treatment (Noordin et al., 2007).  
Detection methods for brugian filariasis include night blood examination, 
polymerase chain reaction (PCR) and diagnostic kits such as Brugia Rapid and 
panLFrapid. Traditional diagnosis of brugian filariasis is by using finger-prick blood 
sample to detect the presence of Mf in blood under microscope. This method is lack 
of sensitivity (25%-40% sensitive) because of the low density of Mf, inability to 
detect cryptic and occult infections (Noordin, 2007). Apart from low sensitivity, the 
main disadvantage of this diagnosis is the nocturnal periodicity of Mf as they are 
primarily circulated at night and require night blood collection (Rahmah et al., 2001a). 
The PCR method has high sensitivity for low levels of Mf but still require the night 
blood sampling as the parasite must be circulating during the sampling time (Noordin, 
2007; TWAS Newsletter, 2011).  
The advantages of antigen detection test to detect active filarial infections are 
the convenience of examination because blood sample can be collected anytime and it 
is more sensitive compared to the traditional Mf detection (Weil and Ramzy, 2007). 
For bancroftian filariasis, the BinaxNOW filariasis immunochromatographic test (ICT 
card) has been widely used for LF elimination programs to detect the W. bancrofti 
antigen (DPDx- Laboratory Identification of Parasitic Diseases of Public Health 
Concern, 2013). A new rapid antigen test (Alere Filariasis Test Strip) had been 
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introduced by Weil and colleagues in year 2013. In their studies, both ICT card and 
Alere Filariasis Test Strip possessed similar high rates of sensitivity and specificity 
(both >99% of sensitivity and specificity) (Weil et al., 2013). Therefore, for the 
detection of brugian filariasis, there is a need for antigen detection test which can 
provide good results (similar with ICT card test and Alere Filariasis Test Strip) and 
can be easily performed anytime without the need of highly trained technical staff for 
on-site diagnosis.  
 
1.5 BmR1 antigen from Brugia malayi 
 The BmR1 recombinant antigen expressed by gene Bm17DIII from B. malayi 
has been employed in both enzyme-linked immunosorbent assays (ELISA) and 
Brugia Rapid. Preliminary test based on ELISA demonstrated that BmR1 recombinant 
antigen possessed high diagnostic value and is patented in Malaysia (2007) and 
Indonesia (2009) (TWAS Newsletter, 2011). Studies showed that the immunogenicity 
of BmR1 antigen is clearly different from other filariasis diseases including 
bancroftian filariasis. Evaluation of the diagnostic tests revealed that the antigen had a 
sensitivity of 93%-100% for the detection of Mf and it is highly specific (99%-100%) 
to detect brugian filariasis (Noordin et al., 2004; Rahmah et al., 2001b). Therefore, 
BmR1 antigen would be a convincing candidate for antigen detection test. 
 
1.6 Application of computational approach 
As mentioned in Section 1.5, BmR1 antigen has been shown to be important as 
a promising biomarker to detect brugian filariasis. However, its structure and function 
has not been characterized. The identification of the structure and function of this 
antigen can provide valuable insights to enhance the understanding of this protein. 
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Besides, knowledge and understanding of antigen-antibody interactions is important 
in leading to the development of antigen detection test. In order to achieve this, 
computational approach plays crucial roles. 
Advances in experimental and computational approach are important to obtain 
the protein three-dimensional (3D) structure and information of antigen-antibody 
interactions. With the increasing number of deposited protein structure from X-ray 
crystallography or nuclear magnetic resonance (NMR) spectroscopy in PDB, the data 
is highly beneficial to the computational approach that utilized information from the 
experimentally determined protein structures. Molecular modelling may not be as 
accurate as experimental method but they often reveal the molecular insight from the 
predicted structure which is useful to complement the experimental approach and 
provide fundamental understanding (Petrey and Honig, 2005).  
On the other hand, molecular docking can provide a detailed understanding of 
the protein-protein interaction e.g. specific interaction between antigen and antibody. 
Protein-protein docking is important especially when the binding interaction of the 
antibody and antigen is unknown (Simonelli et al., 2010; Kuroda et al., 2012). In 
order to predict the antigen-antibody complexes, the docking simulation will require 
the structures of the interacting proteins which are important to yield accurate antigen-
antibody complexes (Rajkannan and Malar, 2007; Kuroda et al., 2012). This is due to 
the antigen-antibody docking algorithms utilize the information that the epitopes of an 
antigen bind specifically to the paratope of an antibody and these binding sites can be 
predicted from their structures. 
Due to the rapid progress in computational method, the successful rates are 
increasing over the years with numerous successful examples have been reported. In 
year 2011, Chlamydia trachomatis protein CT296 was determined using both 
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computational method (I-TASSER) and X-ray crystallography method. The result 
showed that the structure of CT296 predicted by I-TASSER has overall structural 
similarity (root mean square , RMSD of 2.72  Å for 101/137 residues) to the high-
resolution X-ray crystallography structure (1.8 Å). This clearly showed that 
computational method is able to predict accurate protein structures despite having no 
homologs to deposited protein structure (Kemege et al., 2011).  
Successes in the structure prediction for gas vesicle protein GvpA have also 
been reported (Strunk et al., 2011; Ezzeldin et al., 2012). The structure prediction of 
GvpA protein from haloarchaeon Haloferax mediterranei was first carried out by 
Strunk and colleague via computational ab initio method (Rosetta). The predicted 
structure suggests that GvpA possess two α-helices and two β-strands. The secondary 
structure elements (α-β-β-α) is similar with the NMR structures obtained for GvpA 
from cyanobacterium Anabaena flos-aquae (Sivertsen et al., 2010). Mutation in α-
helix and β-turn affected the ability to form gas vesicle. This in vivo data on GvpA 
mutants support the major structural features from the proposed structures (Strunk et 
al., 2011). In subsequent year, Ezzeldin and colleagues predicted GvpA protein from 
Halobacterium sp. NRC-1 with computational comparative modelling (MODELLER 
and SCRATCH), threading (by I-TASSER) and ab initio modelling (Rosetta) (Strunk 
et al., 2011; Ezzeldin et al., 2012). All the predicted structures were equilibrated 
through molecular dynamics (MD) simulation. Average MM-PBSA energy and 
standard deviation were calculated and ranked. From the comparison of the top 
ranked predictions structures and an earlier model proposed by Strunk et al., it 
showed that despite belonging to different organisms, the two sequences possess 93% 
identity (Strunk et al., 2011; Ezzeldin et al., 2012).  Furthermore, the structures with 
an α-β-β-α secondary structure is in agreement with the previous experiment data 
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(Sivertsen et al., 2010) and their studies of secondary structure prediction (Ezzeldin et 
al., 2012). The predicted model supports the hypothesis that homologous sequences 
synthesized by different organisms should possess similar structures (Ezzeldin et al., 
2012). 
Computational approach was performed to identify the important residues in 
the binding site of single chain variable fragment (scFv) against epitope of Gag p55 
polyprotein of human immunodeficiency virus type 1 (HIV-1) by Lee and colleagues 
(Lee et al., 2010). In their study, scFv was modelled from its X-ray structure 
homologues and the antigen-antibody complexes were generated by computational 
docking (Lee et al., 2010). Their studies revealed that the key residues were located at 
the complementarity-determining regions (CDRs) of scFv and they played a crucial 
role in the binding interaction. In addition, the binding activities from their result 
showed that the calculated binding free energy had a good correlation with the 
experimental data (r
2
 = 0.88). In the subsequent study, Tue-Ngeun and colleagues 
identified that the key residues were located at the hot spot of the surface between 
scFv and the antigen through computational alanine scanning. From the analysis, new 
antibodies were designed by the mutation of these key residues (Tue-Ngeun et al., 
2014). Therefore, it showed that computational approach is efficient to generate 
protein structure and identify the key residue in antigen-antibody interaction as well 
as to design a new specific scFv with better binding affinity with the given antigen. 
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1.7 Content of the thesis 
 This chapter (Chapter One) discusses the statement of the problem, various 
aspects of lymphatic filariasis and the importance of BmR1 antigen. Applications of 
computational approaches along with the success cases were also being described 
here. 
Chapter Two provides the details on the prediction of the 3D structure of 
BmR1 antigen via different approaches. The refinement and dynamics of BmR1 
protein were also being described for the identification of potential epitopes. 
 Chapter Three details the design and generation of scFv specific to BmR1 
antigen. The selection criteria for the scFv models were provided and insights into 
BmR1-scFv interactions were also being discussed. 
 Chapter Four summarizes the studies in Chapter Two and Three. The possible 
future directions were also included in this chapter.  
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1.8 Objectives 
The general objectives are: 
i) To predict the structure and epitopes of BmR1 antigen, and 
ii) To design scFv specific toward BmR1 antigen 
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CHAPTER TWO 
THE STRUCTURE AND EPITOPES PREDICTION OF BMR1 PROTEIN 
FROM BRUGIA MALAYI 
 
2.1 Protein structure prediction 
Specific function and mechanism of a protein can be derived from the 3D 
structure of a protein. The most accurate way to determine a high resolution protein 
structure is through experimental methods such as X-ray crystallography or NMR 
spectroscopy (Wu and Zhang, 2009; Nguyen and Madhusudhan, 2011). Even though 
experimentally determined structures will normally possess high resolution structure 
information about a protein, it is a time consuming process without guaranteed 
success (Schwede et al., 2003). There are also limitations in experimental method 
such as cost in handling the experiment and some proteins cannot be crystallized 
easily (Mizianty and Kurgan, 2011). When experimentally determined structures are 
unavailable, the predictive structures may serve as starting points to study the possible 
function of a protein. They can often reveal important information of a protein. These 
information, including the protein‟s folding, evolution, function as well as the protein-
protein interactions that could generate testable hypotheses which is useful to 
complement the experimental information (Petrey and Honig, 2005; Wooley and Ye, 
2007). Therefore, it leads to the rapid growth and importance of computational protein 
structure prediction.  
Protein structure prediction is a method of translating the protein sequence 
into 3D structure by employing computer algorithms. Protein structure prediction is 
still one of the most challenging problems in computational structural biology 
nowadays despite the significant progress in recent years showed by critical 
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assessment of protein structure prediction (CASP) experiments (Zhang, 2008). As of 
December 2014, the Protein Data Bank has over 100,000 deposited protein structures 
(www.rcsb.org) (Berman et al., 2000). Although the number of experimentally solved 
protein structures is increasing at an accelerated rate, at the same time, numbers of 
known protein sequences from genome sequencing projects are increasing at a 
breathtaking pace. To bridge the protein sequence-structure gap, computational 
protein 3D structure predictions from its amino acid sequence provide potential 
solution (Webb and Sali, 2014).  
Computational methods for predicting protein 3D structures can be generally 
divided into three categories: comparative modelling, threading and ab initio. It can 
also be categorized into template-based (TBM) and template-free (FM) modelling 
(Källberg et al., 2012; Maurice, 2014). Comparative modelling and threading method 
are categorized into TBM as they depend on the availability of a template from solved 
protein structure (Fiser, 2010). FM (also known as ab initio or de novo method) is 
potentially able to predict protein structures without any template (Moult et al., 2011; 
Maurice, 2014). The general overview of protein structure prediction is illustrated in 
Figure 2.1. 
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Figure 2.1 General overview of protein structure prediction from its primary sequence 
to three-dimensional (3D) structure through template-based modelling (TBM) or 
template-free modelling (FM).  
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2.1.1 Template-based modelling (TBM) 
To date, comparative modelling is the most successful and accurate 
computational method to produce a reliable protein 3D structure from its amino acid 
sequence. The accuracy of protein structure increases with the accumulation of 
experimentally determined structures in the database (Yan et al., 2013). The idea 
behind comparative modelling is evolutionarily related proteins with at least 30% 
sequence identity will usually share similar structures as the structures and functions 
of proteins are often conserved (Errami et al., 2003; Schwede et al., 2003; Mihăşan, 
2010; Choong et al., 2011). Comparative modelling predicts the 3D structure of a 
target protein based on its alignment to one or multiple templates from protein of 
known structures deposited in a database (Martí-Renom et al., 2000; Eswar et al., 
2008). Comparative modelling consists of four main steps: fold assignment that 
identifies similarity between target sequence and templates, template-target alignment, 
model building and model evaluation (Martí-Renom et al., 2000; Eswar et al., 2003; 
Eswar et al., 2008). The identification of templates can be facilitated by numerous 
structure databases available online such as Protein Data Bank (PDB) (Berman et al., 
2000), CATH (Knudsen and Wiuf, 2010) and Structural Classification of Proteins 
(SCOP) (Conte et al., 2000). The target sequence can be compared with the solved 
protein sequences using pair-wise sequence-sequence comparison in order to obtain 
related protein structures by sequence similarity alignment and search tools e.g 
BLAST (Altschul et al., 1990), FASTA (Pearson and Lipman, 1988), GPU-BLAST 
(Vouzis and Sahinidis, 2011), mpiBLAST (Darling et al., 2003) and G-BLAST (Zhao 
and Chu, 2014). BLAST from NCBI is the most widely used bioinformatics tool to 
search for similar sequences (Vouzis and Sahinidis, 2011; Zhao and Chu, 2014). 
Other factors that need to be taken into consideration during the selection of suitable 
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template(s) including the protein family and quality of the experimentally determined 
structures (Marti-Renom et al., 2002).  
Threading, also known as fold recognition, is another TBM technique used to 
identify structural similarity of evolutionally remotely related protein templates (Roy 
et al., 2010; Roy and Zhang, 2012). The concept for threading is similar to 
comparative modelling but comparative modelling only considers sequence similarity 
between target protein and template while protein threading considers the structural 
information in the template (Xu et al., 2008). The critical step of threading is to 
identify correct template proteins with similar folds to the target protein and make 
correct alignment (Wu and Zhang, 2008). Threading methods compare a target 
sequence against one or more protein 3D structures to detect and obtain best 
compatibility of sequence-structure template pair (Xu et al., 2008; Wu and Zhang, 
2009). The best fit of target sequence with the fold template based on the generated 
alignments is identified and each template is calculated according to different scoring 
function. Commonly used alignment scores to identify precise target-template 
alignments include sequence profile-profile alignments (PPA), sequence-structural 
profile alignments, secondary structure match, hidden-Markov models (HMM) and 
residue-residue contacts (Wu and Zhang, 2009). The alignment algorithms are able to 
search for remotely homologous sequences in the databases. Therefore, even if the 
sequence similarity is relatively low (<30%), threading method can be used to obtain 
the similar fold or similar structural motif for the target sequence. PPA, which can be 
used to detect weak similarities between protein families, is most often-used and 
popular threading approach which performed better than other algorithm as it can 
detect weak similarities between protein families (Yona and Levitt, 2002; Wooley and 
Ye, 2007; Yan et al., 2013).    
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2.1.2 Template-free modelling (FM) 
When there is no homologous structure in PDB or the relationship is so distant 
until it cannot be detected, an ab initio approach is the alternative way to generate the 
structure from scratch (Wu and Zhang, 2009). This type of prediction is termed 
template-free modelling (FM) (also termed as ab initio or de novo modelling) as it 
originally referred to methods that based on the first principle laws of physics and 
chemistry. The idea is based on Anfinsen‟s thermodynamic hypothesis. According to 
the hypothesis, the protein structure was determined solely by its amino acid sequence 
(Anfinsen, 1973; Wooley and Ye, 2007; Hoque et al., 2009). The prerequisite of these 
modelling methods is that the native structure has the global minimum free energy 
among all available conformations (Roy and Zhang, 2012). Therefore, efficient and 
reliable algorithm is important to limit the conformational space in order to minimize 
the energy function so that the protein tends to be in its native state (Bonneau and 
Baker, 2001; Ishida et al., 2003).  
There are a variety of methods developed for ab initio protein structure 
generation. The leading approach is the fragment-based assembly method, an idea of 
Bowie and Eisenberg (Bowie and Eisenberg, 1994). Based on this idea, Rosetta 
(Bonneau et al., 2001) is developed and is a leading method for FM approach as 
Rosetta is able to produce accurate models that are nearer to native structures (Simons 
et al., 1997; Bonneau and Baker, 2001; Simoncini and Zhang, 2013). The idea of this 
approach is that the smaller fragments are restricted to the local structures by the 
closely related sequence in protein structure database (Simons et al., 1997; Ishida et 
al., 2003). The lengths of the fragments vary with programs and the fragment libraries 
are fragments from high resolution solved protein structures. In Rosetta, fragment 
libraries of three- and nine-residue are exploited (Bonneau et al., 2001). Generation of 
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fragments is important in Rosetta after the completion of secondary structure 
prediction and it can be performed through Robetta server (Chivian et al., 2003; 
Chivian et al., 2005). This program iterates over three- and nine-residue of the 
sequence and looks for similar sequences from the fragment libraries to guide the 
search of conformational space in predicting protein structures (Kim et al., 2004). In 
QUARK, the models are assembled from small continuous fragments ranged from 1-
20 residues excised from unrelated proteins (Zhang, 2013). Both Rosetta and QUARK 
showed the importance of assembling structural models using small fragments by 
their significant performance in CASP9 (Kinch et al., 2011). In CASP10, QUARK 
successfully predicted model with largest size range in FM modelling (>150 residues) 
(Xu and Zhang, 2013a).  
 
2.1.3 Current trend in protein structure prediction 
 Recently, the borders between the types of protein structure prediction 
methods have overlapped. Recent CASP experiments demonstrated that composite 
approaches can achieve additional advantages in structure prediction. Since no single 
approach can perform better than others for all protein prediction, the emergence of 
recent trend is combination/hybrid of different protein structure prediction approaches 
(Roy and Zhang, 2012; Zhang, 2013). 
I-TASSER (Iterative Threading ASSEmbly Refinement) is one of the notable 
successful composite approaches in the CASP experiments (Roy et al., 2010). I-
TASSER method is based on the secondary structure enhanced profile-profile 
threading alignment extended from TASSER algorithm for iterative structure 
assembly and refinement of protein molecules (Zhang, 2008; Zhang and Skolnick, 
2013). I-TASSER retrieves structural template from PDB library through a meta-
threading server, termed LOMETS. By year 2010, the online I-TASSER server has 
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generated more than 30,000 full-length structure and function predictions for more 
than 6,000 registered users (Roy et al., 2010). I-TASSER can consistently predict 
correct folds and sometimes high-resolution for small single-domain protein (<120 
residues) with a lower computational time (5 CPU hours for I-TASSER but 150 CPU 
days per target for Rosetta) (Wu et al., 2007). In CASP7, CASP8, CASP9 and 
CASP10, I-TASSER was ranked as the best server for protein structure prediction 
(Nahar et al., 2014). 
 In year 2013, Bhageerath-H Strgen, another homology/ab initio hybrid 
algorithm was developed (Dhingra and Jayaram, 2013). The method was tested in 
CASP9 experiments and showed 93% of the targets were in the pool of decoys. The 
results showed that Bhageerath-H Strgen is capable to search the protein fold for 
near-native conformation. Strategies in Bhageerath-H Strgen include secondary 
structure prediction, database search for sequence based on the input amino acid 
sequence, fold recognition, template-target alignment and template-based modelling 
by MODELLER (Webb and Sali, 2014). The missing residues with no fragments are 
modelled using Bhageerath ab initio modelling. In their study, the results showed that 
Bhageerath-H Strgen performs better than Rosetta and I-TASSER. 
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2.2 Specific aim and objective 
The specific objectives are: 
i) to predict and evaluate the three-dimensional structure of BmR1 
antigen from B. malayi through different in silico approaches, and 
ii) to predict the potential epitope(s) of the BmR1 antigen. 
 
2.3 Methodology 
2.3.1 Overview of the method 
 The overview of this study is illustrated in Figure 2.2. Sequence alignment and 
analysis against the available online database and tools were carried out in order to 
obtain the suitable templates, to identify the domain of the protein and to annotate the 
protein function. Subsequently, the protein structure was predicted and the quality of 
the structure was evaluated. Molecular dynamics (MD) simulation was performed in 
order to further minimize and refine the best predicted structure. Finally, the linear 
and conformational epitopes as well as binding site of BmR1 antigen were identified 
from the structure. 
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Figure 2.2 The overall methodology for structure and epitope prediction of BmR1 
protein from B. malayi.  
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2.3.2 Sequence analysis 
The amino acid sequence of BmR1 protein was retrieved from GenBank with 
the accession number: AF225296. ProtParam from Expert Protein Analysis System 
(ExPASy) Proteomics Server (Gasteiger et al., 2003) was implemented to calculate 
the protein molecular weight. The 206 residues of BmR1 protein was subjected to 
BLAST search against non-redundant (nr) protein sequences to identify similar 
protein family. BLASTp search with default parameters against PDB was performed 
to identify suitable templates (sequence identity >30%). To assist the study on tertiary 
structure prediction, secondary structure prediction on BmR1 protein was performed 
using Jpred3 (Cole et al., 2008), PORTER (Pollastri and McLysaght, 2005), 
PSIPRED (Buchan et al., 2010) and SSpro 4.0 (Cheng et al., 2005). Function 
annotation and identification of the conserved domain were carried out using 
Conserved Domain Search Service (CD Search) (Marchler-Bauer and Bryant, 2004; 
Marchler-Bauer et al., 2011), InterProScan (Quevillon et al., 2005), Proteins Families 
database (Pfam) (Finn et al., 2010) and SMART (Letunic et al., 2009). Protein 
function analysis were performed by Motif Scan from ExPASy (Gasteiger et al., 
2003), PDBeMotif (Golovin and Henrick, 2008), ProFunc (Laskowski et al., 2005), 
PROSITE (Sigrist et al., 2013) and STRING (Mering et al., 2005). 
 
2.3.3 Structural prediction and evaluation 
2.3.3.1 Comparative modelling approach  
Multiple sequence alignment was performed prior to the model construction. 
A total of 250 initial models were generated from multiple templates (PDB id: 2G3Y, 
2IE8 (Lee et al., 2006), 3QOE (Kim et al., 2011), 1V32, 2E87, 2R3V (Fu et al., 2008) 
and 3I4Q) to improve the accuracy of structures, followed by secondary structure 
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restraints and loop refinement using MODELLER 9v9 (Appendix A) (Martí-Renom 
et al., 2000). After subsequent steps of secondary structure restraints and loop 
refinement, the best model was selected based on Discrete Optimized Protein Energy 
(DOPE) score, MODELLER objective function (molpdf) and the quality assessment 
of the model. The molpdf is used to measure the satisfaction of the model input spatial 
restraints (Eswar et al., 2008). DOPE is an atomic distance-dependent statistical 
potential calculated from a set of known native protein crystallographic structures and 
can be used to identify native-like conformation of protein (Shen and Sali, 2006). 
Lower values of the molpdf and DOPE indicate more accurate model (Eswar et al., 
2008). 
 
2.3.3.2 Ab initio approach  
Protein structure prediction by ab initio approach was carried out through 
Rosetta (Bonneau et al., 2001). AbinitioRelax (AbRelax), which is the combination of 
ab initio folding and refinement by Rosetta full-atom force field (Relax), was used to 
create five hundred initial structures (Appendix B). The Relax application makes 
small backbone and side chain torsion movements in order to find a minimum local 
conformation space and Rosetta energy function (Bonneau et al., 2001; Combs et al., 
2013). The input files consisted of the FASTA file of protein sequence, fragments 
library files and the secondary structure prediction files. PSIPRED secondary 
structures file and fragment libraries of three- and nine- residue were generated by 
Robetta fragment server (Chivian et al., 2003). AbRelax combined the generated 
three-mer and nine-mer fragment through fragment assembly method (Kim et al., 
2004) and secondary structure prediction from PSIPRED was used as guideline. 
